www.surgicalnotes.co.uk

Online Information Resource
  • Home
  • About
  • Viva
    • Anatomy
    • Critical care
    • Operative Surgery
    • Pathology
    • Physiology
    • Principles of Surgery
  • Clinical
    • Superficial Lesions
    • Trunk & Abdomen
    • Orthopaedics & Neurosurgery
    • Vascular
    • Communication Skills
  • MRCP
    • Part II: Written
    • Part II: PACES
      • 1: Respiratory & Abdominal
      • 2: History Taking Skills
      • 3: Cardiovascular & CNS
      • 4: Communication Skills & Ethics
      • 5: Skin locomotor eyes
  • USMLE
  • Surgical Sciences
  • Cardiothoracics
  • Medicine
    • Emergencies
    • Vascular Inflammation

Search this site

Critical Care

  • Acute Coronary Syndromes / Myocardial Infarction / Unstable Angina
  • Acute Respiratory Distress Syndrome (ARDS)
  • Agitation / sedation
  • Anaesthesia / premedication
  • Atrial Fibrillation / Flutter
  • Cardiac Pacemaker
  • Cardiovascular support
  • Central lines
  • Head Injury
  • Immobilisation
  • Jugular Venous Pulse (JVP)
  • Mechanical Ventilation
  • Nutrition
  • Pain Managment
  • Renal support
  • Shock / Bleeding / Haemorrhage
  • SIRS / Sepsis / Multi-organ failure

Random medical images gallery

buergersdisease

User login

  • Create new account
  • Request new password
Home | Critical Care

Acute Respiratory Distress Syndrome (ARDS)

Syndrome of (1) acute respiratory failure - PaO2 < 8: FiO2 > 0.6 with (2) non-cardiogenic pulmonary oedema

Leads to: reduced lung compliance, hypoxaemia
50-60% mortality.

  1. PaO2:FiO2 ratio < 26.6kPa (200mmHg)
  2. Pulmonary artery wedge pressure < 16mmHg
  3. Bilateral pulmonary infiltrates

Acute lung injury - similar to above except PaO2:FiO2 <300mmHg

 

Causes

  1. Direct lung injury
    • Pneumonia / pneumonitis / aspiration
    • Smoke inhalation / burns
    • Trauma
  2. Indirect lung injury (cytokine mediated)
    • Multiple trauma
    • Transfusion reaction
    • DIC
    • Pancreatitis
    • Cardio-pulmonary bypass


Pathophysiology

  1. Inflammatory phase: (1) neutrophils/MPs release free radicals, proteases, PGs, ILs, TNF, activate complement (2) Kills type 2 pneumocytes, loss of surfactant (and lung compliance) (3) get lots of lung oedema
  2. Proliferative phase: proliferation of type 2 pneumocytes, increase in fibroblasts
  3. Fibrotic phase (1) odema/secretions reduce compliance and cause atelectasis (2) resulting shunt and hypoxic vasoconstriction and pulmonary hypertension (3)  persisting fibrosis

 

Principles of Management

  1. Treat insult
  2. Fluid restriction/control to prevent worsening oedema
  3. Nutrition
  4. Mechanical ventilation - High PEEP to hold alveoli open; small tidal volumes; Inverse-ratio ventilation; prone ventilation
  5. Treat pulmonary vasoconstriction/hypertension - nitric oxide, inhaled prostacyclin, phosphodiesterase inhibition (viagra)
  6. Treat pulmonary fibrosis - steroids

 

Login or register to post comments
© www.surgicalnotes.co.uk 2007 - 2011